Clinical trial NCT00752388: Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease
Official title: Application of the WHO-5 Well-being Index (WHO-5) as a Screening Instrument for Depression in Parkinson's Disease
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Parkinson Disease
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2008-09-15
Enrollment: 1588
Sex: ALL
Minimum age (years): 30
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: resident physician

Brief summary: To assess the predictive value of sequential administration of WHO-5 and MDI (Major Depression Inventory) for the clinical management of Parkinson Disease (PD) patients by

* determination of the prevalence of depression in PD patients, based on MDI severity categories and the self-rating scale WHO-5, where poor well being was indicated.
* exploration of influencing factors (PD status, therapeutic status) on the prevalence of MDI depression categories.


Eligibility criteria: Inclusion Criteria:

1. PD patients attending one of the participating neurologist practices during 2 fixed weeks in November 2008
2. Idiopathic PD with or without fluctuations
3. Male or female PD patients aged at least 30
4. Ability to reliably complete self-rating scales (WHO-5, MDI) ), according to the physician's judgement.
5. Written informed consent by the patient for study participation.

Exclusion Criteria:

1. PD Patients who only attend the practice to get a prescription and are not seen by the doctor on that day
2. Patients who are not able to understand the questionnaires (e.g. due to mental impairment or language problems).

Primary outcomes:
measure: Prevalence of patients with depressive symptoms (based on WHO-5 and MDI) in total and in subgroups
timeFrame: day 1
Secondary outcomes:
measure: WHO-5 score and items
timeFrame: day 1
measure: MDI score (for a subgroup of patients with WHO-5 score < 13 or any WHO-5 item rated with 0 or 1)
timeFrame: day 1
measure: Correlation of WHO-5 and MDI (for a subgroup of patients with a WHO-5 score < 13 or any WHO-5 item rated with 0 or 1) in PD patients
timeFrame: day 1
measure: Investigator assessment of the applicability of the WHO-5 for screening for depression in PD patients
timeFrame: day 1
Other outcomes:
Locations:
city: Achim
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Achim
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Altenburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Altenholz
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Alzey
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Aue
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bad Driburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bad Homburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bad Honnef
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bad Neuenahr-Ahrweiler
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bad Soden
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Bad Soden
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Bad Sooden-Allendorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bergisch Gladbach
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 10
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 11
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 12
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 13
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 14
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 6
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 7
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 8
city: Berlin
country: Germany
facility: Boehringer Ingelheim Investigational Site 9
city: Bielefeld
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Bielefeld
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Bochum
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Bochum
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Bochum
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Bockhorn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bonn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Braunschweig
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bremen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bremerhaven
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Bretten
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Butzbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Butzbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Buxtehude
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Castrop-Rauxel
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Chemnitz
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Cloppenburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Coesfeld
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Cottbus
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Cottbus
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Delmenhorst
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Dessau
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Dessau
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Dietzenbach
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Dippoldiswalde
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Dortmund
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Dortmund
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Dortmund
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Dresden
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Dresden
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Dresden
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Dresden
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Duisburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Duisburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Duisburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Duisburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Dülmen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Düsseldorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Düsseldorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Düsseldorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Düsseldorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Düsseldorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Erbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Erbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Erftstadt
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Essen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Frankfurt
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Frankfurt
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Freiburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Fürstenwalde
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Gelnhausen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Gelsenkirchen
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Gelsenkirchen
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Gengenbach
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Gera
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Gießen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Gifhorn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Gladenbach
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Goch
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Grünstadt
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Göttingen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Güstrow
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Güstrow
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Gütersloh
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Halle
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Halle
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Halle
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Hamburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Hamburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Hamburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Hamburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Hamburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Hameln
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Hannover
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Hannover
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Hannover
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Hannover
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Heidelberg
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Heidelberg
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Heilbronn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Hemmoor
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Hennigsdorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Henstedt-Ulzburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Herborn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Herzberg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Herzogenrath
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Hildesheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Hildesheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Hildesheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Hildesheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Hildesheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Homburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Hückelhoven
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Hürth
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Ilmenau
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Ilmenau
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Ingelheim
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Iserlohn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Itzehoe
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kamen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kamp-Lintfort
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kandel
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Karlstadt
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kassel
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Kassel
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Kaufbeuren
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kiel
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kleinblittersdorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Kleve
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 6
city: Köln
country: Germany
facility: Boehringer Ingelheim Investigational Site 7
city: Lappersdorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Lauterbach
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Leer
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Leer
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Leipzig
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Leipzig
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Leipzig
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Leipzig
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Leipzig
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Leverkusen
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Leverkusen
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Ludwigsfelde
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Ludwigshafen
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Ludwigshafen
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Ludwigshafen
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Ludwigslust
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Löbau
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Lüdenscheid
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Lüdenscheid
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Lüdenscheid
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Lüdenscheid
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Lüdenscheid
country: Germany
facility: Boehringer Ingelheim Investigational Site 5
city: Lüneburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Lüneburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Lünen
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Lünen
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Magdeburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Malente
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Mannheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Mannheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Mannheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 4
city: Markkleeberg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Marl
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Memmingen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Menden
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Mittweida
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Mönchengladbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Mönchengladbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Mönchengladbach
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Mühlacker
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Mülheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Mülheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Mülheim
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Münster
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Münster
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Münster
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Naumburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Neubrandenburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Neuenhagen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Neukirchen-Vluyn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Neumünster
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Neustadt
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Norden
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Nordhorn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Nübel
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Oberndorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Offenbach
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Oldenburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Oranienburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Oschatz
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Osnabrück
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Paderborn
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Pirmasens
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Plauen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Potsdam
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Quakenbrück
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rastatt
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rathenow
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Regensburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Regensburg
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Remscheid
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rendsburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rheine
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Ribnitz-Damgarten
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Riesa
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rostock
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Rostock
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Rostock
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Rödermark
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rüdersdorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Rüsselsheim
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Salzgitter
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Schirgiswalde
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Schleiden
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Schriesheim
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Schwelm
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Schwerin
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Schwerin
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Seeheim-Jugenheim
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Senftenberg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Solingen
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Solingen
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Solingen
country: Germany
facility: Boehringer Ingelheim Investigational Site 3
city: Stade
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Stade
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Stollberg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Stralsund
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Stralsund
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Strausberg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Sömmerda
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Telgte
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Teltow
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Torgau
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Trier
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Troisdorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Vechta
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Velen
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Velen
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Verden
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Verden
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Viersen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Villingen-Schwenningen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Voerde
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Warendorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Warendorf
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Wedel
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Weida
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Weil am Rhein
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Weißenfels
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Werdau
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Wesseling
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Wetzlar
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Weyhe
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Wismar
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Wismar
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Wolfratshausen
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Wolgast
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Wunstorf
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Wuppertal
country: Germany
facility: Boehringer Ingelheim Investigational Site 1
city: Wuppertal
country: Germany
facility: Boehringer Ingelheim Investigational Site 2
city: Würzburg
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Zella-Mehlis
country: Germany
facility: Boehringer Ingelheim Investigational Site
city: Zwickau
country: Germany
facility: Boehringer Ingelheim Investigational Site
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References: